Auxly Cannabis Group Reports Strong Q2 2025 Financial Results

The latest update is out from Auxly Cannabis Group ( (TSE:XLY) ).

Auxly Cannabis Group reported a robust financial performance for the second quarter of 2025, with net revenues increasing by 33% year-over-year to $38.8 million and a significant increase in net income by 315% to $8.3 million. The company also improved its gross margin to 52% and achieved an adjusted EBITDA of $11.6 million, reflecting a 123% increase. The company has strengthened its balance sheet by amending senior debt and converting remaining debt into equity, which reduces interest expenses and supports long-term growth. Auxly’s market leadership is reinforced by its top-selling cannabis brands and products, and the company aims to continue leveraging its scale to deliver sustainable financial performance.

Spark’s Take on TSE:XLY Stock

According to Spark, TipRanks’ AI Analyst, TSE:XLY is a Neutral.

Auxly Cannabis Group’s stock score is driven by strong technical indicators and a favorable valuation, reflecting positive market momentum and potential undervaluation. Financial performance shows improvement, but ongoing net losses and lack of profitability are concerns. Corporate events highlight improved financial stability, though the absence of earnings calls may affect transparency.

To see Spark’s full report on TSE:XLY stock, click here.

More about Auxly Cannabis Group

Auxly Cannabis Group Inc. is a leading consumer packaged goods company in the cannabis products market, focusing on providing innovative cannabis products to Canadian consumers. It is recognized as the third largest Canadian Licensed Producer with a market share of 6.2% and holds a strong position in the all-in-one vape category.

Average Trading Volume: 815,180

Technical Sentiment Signal: Buy

Current Market Cap: C$201.6M

For a thorough assessment of XLY stock, go to TipRanks’ Stock Analysis page.